Testing a new measure of lupus improvement that encompasses the patients’ perspectives and doctors’ evaluations

Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Anca Askanase and Joan Merrill, the developers of the LFA-REAL tool. Together, they discuss the importance of using a tool like LFA-REAL to understand how clinician and patient reported outcomes are essential for understanding efficacy and effectiveness of experimental therapeutics developed to treat people living with lupus.

 

Read the article: http://dx.doi.org/10.1136/lupus-2022-000875